matchedPattern,context,lineNumber,columnNumber,publicationName
p.G299R,...sense mutations for our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of the...,18,83,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...rlin cDNA or missense-mutated dysferlin cDNA DYSF p.G299R or p.L1341P. Transfected cells were treate...,21,123,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...using an anti-dysferlin ab. (C) merge. (D–F) DYSF p.G299R-GFP tagged. Experiment performed 14×. (D) ...,21,415,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...) Peptide A2 (10-mer) added corresponding to DYSF p.G299R. GFP-dysferlin relocalizes to sarcolemmal ...,21,591,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...y human myotubes obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysfer...,39,144,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...) Peptide A2 (10-mer) added corresponding to DYSF p.G299R. (C) Nonsense peptide added (control). (D–...,42,615,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... influx (FM1-43) in human myotubes harboring DYSF p.G299R or in normal human myotubes is shown at th...,48,66,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...µm boundary area of the plasma membrane. (A) DYSF p.G299R, no peptide. (B) DYSF p.G299R, nonsense pe...",48,289,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"... membrane. (A) DYSF p.G299R, no peptide. (B) DYSF p.G299R, nonsense peptide added. (C) DYSF p.G299R,...",48,319,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...B) DYSF p.G299R, nonsense peptide added. (C) DYSF p.G299R, corresponding mutant peptide A2 added. (D...",48,361,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptide FM1-43 dye rapidly spreads within the DYSF p.G299R human myotubes. After treatment with speci...,48,551,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,ER Stress is Reduced by Treating DYSF p.G299R Expressing myotubes with TAT-Labeled Mutan...,61,39,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... stress sensor BiP in myotubes harboring the DYSF p.G299R mutation compared to normal controls (Fig....,62,229,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,(A) In DYSF p.G299R human myotubes HSPA5 gene expression is si...,65,13,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...t peptides decrease HSPA5 gene expression in DYSF p.G299R human myotubes most effectively (RT-PCR). ...,65,196,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ients with LGMD2B: DYSF c.855+1delG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C; p.L1341P...,91,464,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...o wildtype dysferlin and dysferlin mutations DYSF p.G299R and DYSF p.L1341P 10 and 15mer peptides we...,94,66,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...tle Upon Tyne, UK). DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431...",97,218,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ent the amino-acid sequence corresponding to DYSF p.G299R in the C2B (red) and p.L1431P in the C2E d...,125,300,PLoS_One_2012_Nov_20_7(11)_e49603.txt
